Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) FCF Margin: 2021-2025

Historic FCF Margin for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -54.36%.

  • Biofrontera's FCF Margin fell 4044.00% to -54.36% in Q3 2025 from the same period last year, while for Sep 2025 it was -32.19%, marking a year-over-year increase of 1932.00%. This contributed to the annual value of -27.63% for FY2024, which is 4547.00% up from last year.
  • Biofrontera's FCF Margin amounted to -54.36% in Q3 2025, which was down 59.18% from -34.15% recorded in Q2 2025.
  • Biofrontera's FCF Margin's 5-year high stood at 1.82% during Q2 2022, with a 5-year trough of -229.05% in Q4 2021.
  • In the last 3 years, Biofrontera's FCF Margin had a median value of -42.75% in 2024 and averaged -53.29%.
  • In the last 5 years, Biofrontera's FCF Margin soared by 14,749bps in 2022 and then tumbled by 17,837bps in 2023.
  • Quarterly analysis of 5 years shows Biofrontera's FCF Margin stood at -229.05% in 2021, then spiked by 14,749bps to -81.56% in 2022, then tumbled by 208bps to -83.64% in 2023, then surged by 7,599bps to -7.64% in 2024, then plummeted by 4,044bps to -54.36% in 2025.
  • Its FCF Margin stands at -54.36% for Q3 2025, versus -34.15% for Q2 2025 and -47.97% for Q1 2025.